Catalyst Wire Dossier Catalyst Wire Dossier

Ambrisentan (generic)

Ambrisentan · Cipla USA Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ambrisentan (generic), covering 2019-04-26 to 2019-04-26. Get the full timeline:

Most recent: FDA Approved: AMBRISENTAN — Original Application (Cipla USA Inc.)

See pricing